RENB
Lunai Bioworks Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
David H. Weinstein
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Lunai Bioworks Inc.
CEO
David H. Weinstein
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 27 Jun 2024 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 62,112 | $1.61 |
| 27 Jun 2024 | Alton Gregg H | director | A-Award | Acquired | 48,137 | $1.61 |
| 27 Jun 2024 | SAPIRSTEIN JAMES | director | A-Award | Acquired | 48,137 | $1.61 |
| 19 Mar 2024 | SAPIRSTEIN JAMES | director | A-Award | Acquired | 28,196 | $2.66 |
| 22 Feb 2024 | Sindlev Rene | director, 10 percent owner: | X-InTheMoney | Acquired | 471,699 | $0.53 |
| 22 Feb 2024 | Sindlev Rene | director, 10 percent owner: | X-InTheMoney | Disposed | 471,699 | $0.53 |
| 16 Feb 2024 | Dybul Mark | director, officer: Chief Executive Officer | A-Award | Acquired | 2,000,000 | $1.92 |
| 16 Feb 2024 | Dybul Mark | director, officer: Chief Executive Officer | A-Award | Acquired | 450,000 | $1.92 |